tiprankstipranks
HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
Canadian Market

HLS Therapeutics Inc (HLS) Income Statement

Compare
44 Followers

HLS Therapeutics Inc Income Statement

Last quarter (Q4 2024), HLS Therapeutics Inc's total revenue was $15.54M, a decrease of -2.02% from the same quarter last year. In Q4, HLS Therapeutics Inc's net income was $-3.02M. See HLS Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 56.62M$ 63.07M$ 61.47M$ 60.01M$ 56.11M
Gross Profit
$ 47.62M$ 55.45M$ 56.49M$ 56.04M$ 52.48M
Operating Expenses
$ 47.62M$ 55.45M$ 69.98M$ 62.32M$ 64.57M
Depreciation and Amortization
$ 22.72M$ 31.94M$ 34.40M$ 30.26M$ 33.19M
EBITDA
$ 17.22M$ 12.88M$ 18.00M$ 25.41M$ 23.19M
Operating Income
$ 0.00$ -10.35M$ -13.44M$ -6.24M$ -11.26M
Other Income/Expenses
$ -15.58M$ -17.45M$ -10.22M$ -5.52M$ -4.21M
Pretax Income
$ -15.58M$ -27.80M$ -23.72M$ -11.81M$ -16.30M
Net Income
$ -19.66M$ -27.53M$ -23.60M$ -13.12M$ -15.33M
Per Share Metrics
Basic EPS
$ -0.62$ -0.85$ -0.73$ -0.41$ -0.48
Diluted EPS
$ -0.62$ -0.85$ -0.73$ -0.41$ -0.48
Weighted Average Shares Outstanding
31.57M 32.26M 32.33M 32.18M 31.71M
Weighted Average Shares Outstanding (Diluted)
31.83M 32.26M 32.43M 32.18M 31.71M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis